Internal Server Error

Biocartis - About the company

Biocartis is a public company based in Mechelen (Belgium), founded in 2007 by Rudi Pauwels. It operates as a Manufacturer of automated molecular diagnostic systems for oncology biomarker testing. Biocartis has raised $305M in funding from investors like Johnson & Johnson Innovation – JJDC, Aescap and Debiopharm. The company has 270 active competitors, including 69 funded and 45 that have exited. Its top competitors include companies like GRAIL, UDX and Exact Sciences.

Company Details

Manufacturer of automated molecular diagnostic systems for oncology biomarker testing. These systems perform molecular analysis on tissue samples to detect genetic mutations and gene fusions. The technology supports clinical decision-making by providing results for various cancer types. The hardware and associated assays facilitate the identification of biomarkers required for treatment selection.
Social
XFacebook
Email ID
*****@biocartis.com
Phone Number
+32 **********
Registered Address
Jersey City, New Jersey
Key Metrics
Founded Year
2007
Location
Mechelen, Belgium
Stage
Public
Total Funding
$305M in 18 rounds
Latest Funding Round
Ranked
Annual Revenue
€10M - €50M as on Dec 31, 2024
Employee Count
314 as on Sep 30, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Public

Biocartis's IPO details

Biocartis got listed on Apr 27, 2015.
Click here to take a look at Biocartis's IPO in detail
Sign up to download Biocartis' company profile

Biocartis's funding and investors

Biocartis has raised a total funding of $305M over 18 rounds. Its first funding round was on Oct 15, 2009. Biocartis has 20 institutional investors.

Here is the list of recent funding rounds of Biocartis:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Sep 01, 2022
9448592
Post IPO
4942281
1921283
3001870
5465862
May 11, 2021
1909175
Grant (prize money)
5391019
8230124
8672011
Dec 07, 2020
1448723
Post IPO
3287303
1774278
5541973
8975314
lockAccess funding benchmarks and valuations. Sign up today!

Biocartis' founders and board of directors

Founder? Claim Profile
The founders of Biocartis is Rudi Pauwels.
Here are the details of Biocartis' key team members:

Biocartis' employee count trend

Biocartis has 314 employees as of Sep 26. Here is Biocartis's employee count trend over the years:
Employee count trend for Biocartis
lockUncover Biocartis' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Biocartis's Competitors and alternates

Top competitors of Biocartis include GRAIL, UDX and Exact Sciences. Here is the list of Top 10 competitors of Biocartis, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for GRAIL
GRAIL
2016, Menlo Park (United States), Public
Developer of a screening platform for circulating tumor DNA to detect cancer
$2B
79/100
2nd
Logo for UDX
UDX
2012, Seville (Spain), Series C
Developer of non-invasive blood-based diagnostics for cancer
$105M
69/100
3rd
Logo for Exact Sciences
Exact Sciences
1995, Madison (United States), Acquired
Provider of non-invasive molecular diagnostic testing solutions for cancer
-
67/100
4th
Logo for Stilla Technologies
Stilla Technologies
2013, Villejuif (France), Acquired
Developer of digital PCR solution for research
$53.1M
61/100
5th
Logo for Volition
Volition
1995, Gembloux (Belgium), Public
Developer of cancer diagnostic tests
-
61/100
6th
Logo for Biocartis
Biocartis
2007, Mechelen (Belgium), Public
Manufacturer of automated molecular diagnostic systems for oncology biomarker testing
$305M
59/100
7th
Logo for Tethis
Tethis
2004, Milan (Italy), Series A
Provider of automated solutions for in liquid biopsy
$15.3M
56/100
8th
Logo for Mursla
Mursla
2017, London (United Kingdom), Seed
Provider of diagnostic device for cancer detection
$547K
55/100
9th
Logo for GenMark Diagnostics
GenMark Diagnostics
1993, San Diego (United States), Acquired
Provider of instruments and test panels for multiplexed molecular diagnostics
$8.56M
54/100
10th
Logo for Biovica
Biovica
2009, Uppsala (Sweden), Public
Drug response monitoring assay
$4.27M
53/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Biocartis's competitors? Click here to see the top ones

Biocartis's Investments and acquisitions

Biocartis has acquired Pronota. Biocartis has not made any investments as of now.

Reports related to Biocartis

Here is the latest report on Biocartis's sector:

News related to Biocartis

lockFilter this list
Media has covered Biocartis for a total of 4 events in the last 1 year, 3 of them have been about partnerships and 1 about company updates.
•
Biocartis Appoints Ben Svarczkopf as SVP of Global MarketingGlobeNewswire•Jun 17, 2025•Biocartis
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Biocartis

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford